Pergoveris
Pergoveris contains two medications. Follitropin Alfa and Lutropin Alfa, both of which are gonadotropins.. Pergoveris stimulates follicular development in women with LH and FSH deficiency
We recommend ordering 2 weeks in advance!
| Strength | 150IU / 75IU |
|---|---|
| Shipping From | Israel |
| Active Ingredients | Follitropin Alfa / Lutropin Alfa |
| Manufacturer | Serono |
| Manufactured In | Switzerland |
Pergoveris Description
Pergoveris is a vial for injection.
Pergoveris is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials, these patients were defined by an endogenous serum LH level < 1.2 IU/l.
Pergoveris - What's Included
Each vial of Pergoveris contains 150 IU of Follitropin Alfa and 75 IU of Lutropin Alfa (as a powder). Boxes can contain a single vial or 3 vials. There is a glass vial of solution for injection for each vial supplied.
The Difference Between US and European Pergoveris
Pergoveris on IVFPharmacy is made by Serono Pharmaceuticals. It is a brand medication, not generic. The drug composition is exactly the same as Pergoveris in the US, but the packaging may vary slightly.
IVFPharmacy does not supply Pergoveris pens since these require constant refrigeration which cannot be guaranteed on international delvieries.
Pergoveris vials are stable at room temperatire and can have expiration dates of up to 3 years.
Pergoveris Uses and Side Effects
Pergoveris Uses & Indications:
Pergoveris is a fertility medicine used in women to stimulate the development of follicles, the structures inside the ovaries that contain an egg. Pergoveris is for adult women who have low levels of two hormones that stimulate the ovaries – follicle-stimulating hormone (FSH) and luteinising hormone (LH).
Pergoveris Side Effects:
Common side effects with Pergoveris include: headache, ovarian cysts and injection site reactions (e.g. pain, itching, redness, bruising, swelling or irritation at the site of injection). Treatment can cause overstimulation of the ovaries (known as ovarian hyperstimulation syndrome, OHSS), which can lead to serious medical problems. Mild or moderate OHSS is common, while severe OHSS is uncommon. Thromboembolism (clots in the blood vessels) may occur very rarely, usually associated with severe OHSS.
For the full list of all side effects and restrictions with Pergoveris, see the package leaflet.
Disclaimer: information taken from webMD.com
You must be logged in to post a review.
Reviews
There are no reviews yet.
-
(0 customer reviews)